53 research outputs found
Sonographically Guided Patellar Tendon Fenestration
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/135446/1/jum2013325771.pd
Ureter tracking and segmentation in CT urography (CTU) using COMPASS
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134875/1/mp1412_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/134875/2/mp1412.pd
Detection of urinary bladder mass in CT urography with SPAN
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134872/1/mp2503.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/134872/2/mp2503_am.pd
Urinary bladder segmentation in CT urography using deepĂą learning convolutional neural network and level sets
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134923/1/mp4498.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/134923/2/mp4498_am.pd
Posterior Interosseous Nerve of the Elbow
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/135289/1/jum2010295691.pd
An oncocytic adrenal tumour in a patient with BirtâHoggâDubĂ© syndrome
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106917/1/cen12292.pd
Usefulness of the Twinkling Artifact in Identifying Implanted Mesh After Inguinal Hernia Repair
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/135644/1/jum20113081059.pd
Safety of gadoliniumâbased contrast material in sickle cell disease
Purpose: To assess the safety of intravenously administered gadoliniumâbased contrast material in sickle cell disease (SCD) patients. Materials and Methods: All pediatric and adult SCD patients evaluated by magnetic resonance imaging (MRI) at our institution between January 1995 and July 2009 were identified. The medical records of SCD patients who underwent contrastâenhanced MRI as well as an equalâsized cohort of SCD patients who underwent unenhanced MRI were reviewed for adverse (vasoâocclusive and hemolytic) events within 1 week following imaging. Results: Eight (five mild and three moderate) adverse events were documented within 1 week following contrastâenhanced MRI (38 patients and 61 contrast injections), while six (five mild and one moderate) similar events occurred within 1 week following unenhanced MRI (61 patients and 61 unenhanced MRI examinations). This difference in the number of adverse events was not statistically significant (odds ratio = 1.4; 95% confidence interval [CI] 0.4, 5.2). No severe adverse event occurred in either patient cohort. Conclusion: Gadoliniumâbased contrast materials do not appear to be associated with increased risk of vasoâocclusive or hemolytic adverse events when administered to SCD patients. Larger, prospective studies using multiple gadoliniumâbased contrast materials would be useful to confirm the results of our investigation. J. Magn. Reson. Imaging 2011;. © 2011 WileyâLiss, Inc.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/87070/1/22666_ftp.pd
Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors
AbstractOBJECTIVES: The full potential of stereotactic body radiation therapy (SBRT), in the treatment of unresectable intrahepatic malignancies, has yet to be realized as our experience is still limited. Thus, we evaluated SBRT outcomes for primary and metastatic liver tumors, with the goal of identifying factors that may aid in optimization of therapy. METHODS: From2005 to 2010, 62 patients with 106 primary and metastatic liver tumors were treated with SBRT to a median biologic effective dose (BED) of 100 Gy (42.6-180). The majority of patients received either three (47%) or five fractions (48%). Median gross tumor volume (GTV) was 8.8 cm3 (0.2-222.4). RESULTS: With a median followup of 18 months (0.46-46.8), freedom from local progression (FFLP) was observed in 97 of 106 treated tumors, with 1- and 2-year FFLP rates of 93% and 82%. Median overall survival (OS) for all patients was 25.2 months, with 1- and 2-year OS of 81%and 52%. Neither BED nor GTV significantly predicted for FFLP. Local failure was associated with a higher risk of death [hazard ratio (HR) = 5.1, P = .0007]. One Child-Pugh Class B patient developed radiationinduced liver disease. There were no other significant toxicities. CONCLUSIONS: SBRT provides excellent local control for both primary and metastatic liver lesions with minimal toxicity. Future studies should focus on appropriate selection of patients and on careful assessment of liver function to maximize both the safety and efficacy of treatment
Urinary bladder cancer staging in CT urography using machine learning
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/139956/1/mp12510.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/139956/2/mp12510_am.pd
- âŠ